Weight loss drugs may lower risk of dementia, stroke: Study
Patients taking semaglutide or tirzepatide medications — active ingredients in weight loss drugs such as Ozempic, Mounjaro and Wegovy — showed a lower risk of developing certain diseases compared to those taking other, similar medications.
Those include neurodegenerative diseases, such as dementia and Alzheimer's, and cerebrovascular disease, which manifests in strokes, brain aneurysms and more.
Researchers analyzed the health developments over seven years in 60,000 adults aged 40 or older diagnosed with both Type 2 diabetes and obesity, as recorded by the TriNetX U.S. network.
The patients were all users of semaglutide, tirzepatide or other GLP-1 anti-diabetes drugs from December 2017 through June 2024.
The effects were most prominent among women, patients older than 60 and those with a body mass index of 30 to 40.
Researchers acknowledged more clinical trials are needed to corroborate their initial findings, but they maintained the data 'represents one of the most recent clinical database–driven analyses to investigate the neuroprotective and cerebrovascular associations of newer GLP-1RAs' for some patients.
Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Solve the daily Crossword
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Entrepreneur
a minute ago
- Entrepreneur
Dr. Drew and Kim Perell Advise a Founder on How to Fix Her Customer Retention Problem
Get lessons in leadership and setting boundaries from renowned health expert Dr. Drew Pinsky and serial investor Kim Perell on this episode of Entrepreneur Therapy. Amy Beckley, a Ph.D scientist, faced fertility and miscarriage problems due to low levels of the hormone progesterone. After hitting dead ends with traditional fertility tracking, she created Proov, the first FDA-cleared at-home test that helps women track their fertility hormones using a simple urine strip and mobile app. The product worked. Maybe a little too well. The typical customer only sticks around for two months. "We make really effective products that help couples get pregnant," Amy told Dr. Drew Pinsky and Kim Perell on Entrepreneur Therapy, presented by Amazon Business. "Sometimes we get them pregnant too fast, which is great for being a human and for helping people. But not so great for business." So, how does she build customer retention when the very nature of her product means customers no longer need it? Dr. Drew suggests extending the care journey beyond fertility testing. "You need either a partner or something in there so we can actually take care of these problems you're identifying," he says, referencing the perimenopausal issues her customers face that may require ongoing support through supplements, therapeutics, or other interventions. Related: 5 Proven Strategies for Retaining Your Best Customers Perell agrees with the direction, but suggests starting low and going slow. "Don't try to do a lot of partnerships," she says. "Focus on one to two that will have the most value for your business right now." Amy admits that customer retention isn't her only challenge. She talks about her difficulty creating emotional boundaries as the founder of a small company with a deeply personal mission. "When I was building the company," she says, "my friends would tell me, 'If this business fails, it's because you're too nice.' I tend to trust people. I genuinely want to help them, and I give people a lot of chances. That can be really detrimental to the business." Related: The Most Successful Entrepreneurs Know How to Say 'No.' Here's the One Exercise You Need to Learn This Skill. Dr. Drew relates. "I suffer from the same affliction," he says. "You're someone—like me—who experiences yourself through other people. So if we get a lot of negative stuff back, it really gets in. Perell calls this "the disease to please." Their solution? Setting emotional boundaries and reframing decisions in a way that centers on the business, rather than the individual. Perell encourages Amy to ask herself, Is this in the best interest of the company? "Sometimes that means making uncomfortable choices," she warns. But she has a solution for easing the blow when she has to say no. Blame the board. "It takes the pressure off the conversation," she says. "You're not saying no because you don't care; you're saying no because you have a bigger responsibility." It's advice Amy clearly values. "That was amazing," she says at the end of the session. "They had really, really good advice." Watch the episode to learn more about Amy's challenges and the advice Dr. Drew and Perrell give to scale her business. Entrepreneur Therapy is presented by Amazon Business. Smart business buying starts with Amazon Business. Learn more.
Washington Post
2 minutes ago
- Washington Post
An executive lost his job and became a mailman. It wasn't what he expected.
Stephen Starring Grant became a mail carrier at age 50 for a practical reason: He needed health insurance. A longtime consultant and marketing executive, Grant lost his job when covid hit. The layoff was so abrupt that he was in an airport, halfway to a meeting in New York, when he got the call. 'At four that morning, I had been employed,' Grant writes in his new book, 'Mailman.' 'Now I was not.'
CNN
2 minutes ago
- CNN
Black box warning on menopause hormone therapies should be removed, experts say
All menopause treatments containing the hormone estrogen are mandated by the US Food and Drug Administration to carry a black box warning on the label, stating that the treatments could increase the risk of strokes, blood clots, dementia and breast cancer. Now, that advisory may be going away. Last week, a panel of experts convened by the FDA urged the federal agency to remove the cautionary language on at least some forms of hormone therapy. I wanted to understand more about why these warnings were first added and the arguments for and against removing them now. What are hormone therapies used for, and what are the different forms of treatment? What is the history behind adding black box warnings, and why are some experts pushing to remove them? What should women know about managing menopause symptoms? I turned to CNN wellness expert Dr. Leana Wen to answer these questions. Wen is an emergency physician and adjunct associate professor at George Washington University. She previously was Baltimore's health commissioner. CNN: When does menopause occur, and what kinds of symptoms do women experience during menopause? Dr. Leana Wen: Menopause is the stage in a woman's life when her menstrual periods permanently stop. It marks the end of fertility and is accompanied by a decline in reproductive hormones such as estrogen and progesterone. In the US, most women begin the menopause transition between ages 45 and 55, and the average age is 52. The definition of menopause is a full year without having a period. Except in situations where menopause is induced by surgery (for example, removal of ovaries) or specific medical conditions, this period is generally preceded by a stage called perimenopause, when women may have irregular periods and start experiencing menopause symptoms. Symptoms associated with menopause can include hot flashes and night sweats. Hot flashes are sudden sensations of heat, skin flushing and sweating that can significantly disrupt daily activities. About one-third of women have more than 10 hot flashes per day. When they occur at night, they can disrupt sleep and increase fatigue and irritability during the day. Menopausal declines in estrogen also may cause vaginal dryness, decreased libido and discomfort during intercourse. Some women experience other symptoms such as mood changes, anxiety, difficulty concentrating, dry skin and weight gain. Moreover, while this is not a symptom of menopause per se, the risk of developing chronic conditions such as cardiovascular disease and osteoporosis increases significantly after menopause. This rise in risk is thought to be linked to the decline in estrogen levels, as estrogen has a protective effect on maintaining healthy blood vessels and supporting bone density. CNN: What are hormone therapies used for? What are the different forms of treatment? Wen: Hormone therapies are prescription drugs that are used to treat menopause symptoms. They replace the hormones that decline during menopause. It's important to differentiate between two types of hormone therapy. The first is systemic therapy in which hormones are given in a way that is absorbed into the bloodstream. That could be through taking pills or using patches, sprays or gels. Systemic therapy is used to treat symptoms that affect the entire body, such as flashes and night sweats. The second type is low-dose vaginal estrogen therapy. This is a cream or suppository administered into the vagina to treat vaginal dryness and reduce tissue thinning. Unlike systemic therapy, this type of therapy works locally; its purpose is not to raise hormone levels throughout the body. CNN: What is the history behind adding black box warnings, and why are some experts pushing to remove them? Wen: For decades, hormone therapy was considered the standard of care for menopause-related symptoms. Then, in the early 2000s, a landmark study called the Women's Health Initiative was published that suggested hormone therapy increased the risk of breast cancer, heart disease and stroke. It concluded that the benefits of this therapy did not outweigh these risks, leading to the FDA adding the black box warning in 2003. Many researchers have since examined the methodological problems of the study. One significant issue was that the average age of participants was 63. The women studied were mostly postmenopausal, so the question answered was regarding the risks and benefits to postmenopausal women, not menopausal women. Last year, scientists — including some of the original researchers of the Women's Health Initiative — published an updated analysis in the journal JAMA. They concluded that, in fact, hormone treatment with a combination of estrogen and progesterone is safe and effective for treating hot flashes and other systemic symptoms if started before age 60 or within 10 years of starting menopause and if the woman does not have specific contraindications — for instance, an estrogen-sensitive breast cancer. This updated analysis is one reason cited by many advocates to remove the warning. Another major reason is that the black box warning is currently on all types of hormone treatments, including vaginal therapies that deliver far lower doses and do not have the systemic effect of, say, an estrogen-containing pill. Advocates argue that putting all forms of hormone therapy under the same warning misrepresents risk and makes it harder for women to receive relief from troublesome symptoms. Women are still able to access the therapies despite the warning, but some may be more hesitant to use them after seeing the warnings. CNN: What are other arguments for and against this change? Wen: In his opening argument, FDA Commissioner Dr. Marty Makary remarked that systemic hormone therapy, when started within 10 years of the onset of menopause, can actually reduce cardiovascular disease. This finding is suggested by some recent studies, which also show a benefit for bone health. Not everyone agrees that hormone therapy should be taken for preventive purposes. There is also some controversy about process; specifically, the panelists who spoke at last week's FDA meeting were all selected by Makary and all favored hormone therapy. Some have said they would appreciate more balance by hearing from experts who have more nuanced views. In addition, there was no presentation by internal FDA scientists, who, in the past, have given their own analysis during these types of meetings. CNN: While the FDA is considering changing the warning label, what is your advice for women about managing menopause symptoms? Wen: The most important thing is that women who are experiencing significant symptoms during menopause don't need to suffer in silence. Effective treatments exist. Women should speak with their physicians about lifestyle measures that can help as well as hormonal and nonhormonal prescription therapies. They should also speak with their providers about preventive care to improve heart health and prevent bone loss. Those who want additional resources should look to the Menopause Society, which also has a searchable database of clinicians who are certified menopause practitioners and trained to guide women through this transition.
